We are live on
!
Find out more
MDSL
M.D. Sass LLC Portfolio holdings
AUM
$1.32B
1-Year Est. Return
16.01%
This Fund
S&P 500
This Quarter
Est. Return
-5.02%
1 Year Est. Return
+16.01%
3 Year Est. Return
+54.62%
5 Year Est. Return
+70.79%
10 Year Est. Return
+248.43%
AUM
$545M
AUM Growth
+$16.2M
(+3.1%)
Cap. Flow
+$51.4M
Cap. Flow
% of AUM
9.42%
Top 10 Holdings %
Top 10 Hldgs %
54.95%
Holding
35
New
6
Increased
13
Reduced
9
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Charles River Laboratories
CRL
|
+$29.9M |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$26.1M |
| 3 |
Match Group
MTCH
|
+$22.1M |
| 4 |
PayPal
PYPL
|
+$17.1M |
| 5 |
WWE
World Wrestling Entertainment
WWE
|
+$15.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$21.7M |
| 2 |
Quanta Services
PWR
|
+$17.7M |
| 3 |
ON Semiconductor
ON
|
+$14.9M |
| 4 |
Interactive Brokers
IBKR
|
+$14.3M |
| 5 |
East-West Bancorp
EWBC
|
+$10.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 18.91% |
| 2 | Financials | 18.43% |
| 3 | Communication Services | 15.79% |
| 4 | Technology | 13.06% |
| 5 | Healthcare | 12.55% |
Similar funds
LCS
CC
CP
IEFM
GSEP
TIM
MCM
HCM
M.D. Sass LLC's Q3 2022 Portfolio in Review
As of Q3 2022, M.D. Sass LLC held 35 positions worth $545M, up 3.1% from $529M the previous quarter. Its ten largest holdings account for 55% of the portfolio.
M.D. Sass LLC deployed $51.4M of net new capital in Q3 2022, opening 6 new positions and adding to 13 existing holdings. Its largest new stake was Charles River Laboratories: 138,414 shares worth $27.2M.
By sector, the portfolio is most concentrated in Industrials at 19% of assets, down from 23% a quarter earlier, followed by Financials and Communication Services.
On the sell side, the largest reduction was ON Semiconductor, an estimated $14.9M trimmed.
- M.D. Sass LLC's largest Q3 2022 buy was Charles River Laboratories: 138,414 shares worth $27.2M.
- M.D. Sass LLC added most to CACI in Q3 2022, an estimated $10.8M increase.
- M.D. Sass LLC's biggest Q3 2022 reduction was ON Semiconductor, cutting an estimated $14.9M.
- M.D. Sass LLC fully exited Vertex Pharmaceuticals in Q3 2022, selling an estimated $21.7M.
- M.D. Sass LLC's ten largest holdings make up 55% of its $545M portfolio in Q3 2022.
- M.D. Sass LLC opened 6 new positions and closed 4 in Q3 2022.
- M.D. Sass LLC's portfolio value rose 3.1% quarter-over-quarter to $545M.
Based on M.D. Sass LLC's 13F filing for Q3 2022, filed 15 Nov 2022.